Skip to main content
Clinical Trials/CTRI/2011/06/001789
CTRI/2011/06/001789
Completed
Phase 4

TO EVALUATE THE GLYCEMIC AND INSULINAEMIC RESPONSES TO A TEST PRODUCT IN HEALTHY VOLUNTEERS

Roquette Freres0 sites12 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Roquette Freres
Enrollment
12
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 2, 2011
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Volunteers Male / Females, Age between 20\- 60 years.
  • 2\.Body mass index less than 28 kg/m2 i.e. should not be obese.
  • 3\.Cooperating, informed of the need and duration of the study procedures, and ready to comply.
  • 4\.Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives

Exclusion Criteria

  • 1\.Subjects with any chronic illness or any clinical condition.
  • 2\.Fasting glucose more than 110 mg/dl.
  • 3\.Any major illness in the past three months or any clinically significant ongoing chronic medical illness e.g. Congestive cardiac failure, Hepatitis, Hypotensive episodes, etc.
  • 4\.Any medication consumption in the past one week or suffering from any illness.
  • 5\.Subjects consuming alternative system medication (Eg. Ayurvedic and Homeopathic medications).
  • 6\.History of dehydration from diarrhea, vomiting or any other reason within a period of 1 week prior to the study.
  • 7\.Subjects with systolic blood pressure le than 90 mm and more than 140 mm of Hg.
  • 8\.Volunteers on any regular medication for any given medical illness.
  • 9\.Volunteers consuming any medication in the past one week.
  • 10\.An unusual diet, special diet, for whatever reason e.g. high protein diet, low sodium diet, for two weeks prior to receiving any test food and throughout subject?s participation in the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials